Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Diagnosis of Incomplete Kawasaki Disease in Infants Based on an Inflammation at the Bacille Calmette-Gu$\acute{e}$rin Inoculation Site

  • Seo, Ji Hye (Department of Pediatrics, College of Medicine, University of Ulsan) ;
  • Yu, Jeong Jin (Department of Pediatrics, College of Medicine, University of Ulsan) ;
  • Ko, Hong Ki (Department of Pediatrics, College of Medicine, University of Ulsan) ;
  • Choi, Hyung Soon (Department of Pediatrics, Kosin University Gospel Hospital) ;
  • Kim, Young-Hwue (Department of Pediatrics, College of Medicine, University of Ulsan) ;
  • Ko, Jae-Kon (Department of Pediatrics, College of Medicine, University of Ulsan)
  • Published : 2012.12.31
⟨ Previous Next ⟩

Abstract

Background and Objectives: This study was intended to test how the inflammation at the Bacille Calmette-Gu$\acute{e}$rin (BCG) inoculation site (BCGitis) can be a useful a diagnostic feature of Kawasaki disease (KD). Subjects and Methods: All subjects were infants at the time of admission, and had received BCG vaccination during their neonatal period. There were 54 patients with complete KD (group 1) and 29 patients with incomplete KD (group 2). All 83 patients had BCGitis during the acute phase of illness. Data regarding the coronary artery diameters in 31 age-matched controls were used for comparison. Results: The 2 patient groups did not differ in clinical and laboratory variables. During the acute phase, the median z scores of the left anterior descending coronary artery (LAD) diameter were 0.20, 0.42, and -0.48 in groups 1, 2, and control respectively, and that of right coronary artery (RCA) diameters were -0.15, -0.16, and -1.17 respectively. The z scores in both patient groups were greater than those in controls (p=0.0014 in LAD and p<0.0001 in RCA between group 1 and controls; p=0.0023 in LAD and p<0.0001 in RCA between group 2 and controls). A similar pattern was observed during the subacute and convalescent phases. Conclusion: BCGitis is a useful feature in the diagnosis of incomplete KD in infants who received BCG vaccine during neonatal period.

Keywords

References

  1. Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005;47:232-4. https://doi.org/10.1111/j.1442-200x.2005.02033.x
  2. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71. https://doi.org/10.1161/01.CIR.0000145143.19711.78
  3. Sonobe T, Kiyosawa N, Tsuchiya K, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 2007;49:421-6. https://doi.org/10.1111/j.1442-200X.2007.02396.x
  4. Witt MT, Minich LL, Bohnsack JF, Young PC. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics 1999;104:e10. https://doi.org/10.1542/peds.104.1.e10
  5. Cho MA, Choi YJ, Jung JW. Affects of "age at diagnosis" on coronary artery lesions in patients with incomplete kawasaki disease. Korean Circ J 2010;40:283-7. https://doi.org/10.4070/kcj.2010.40.6.283
  6. Lee HJ. Classification of vaccination and immunization schedule recommended by the Korean Pediatric Society, 2008. J Korean Med Assoc 2008;51:104-9. https://doi.org/10.5124/jkma.2008.51.2.104
  7. Chalmers D, Corban JG, Moore PP. BCG site inflammation: a useful diagnostic sign in incomplete Kawasaki disease. J Paediatr Child Health 2008;44:525-6. https://doi.org/10.1111/j.1440-1754.2008.01364.x
  8. Sinha R, Balakumar T. BCG reactivation: a useful diagnostic tool even for incomplete Kawasaki disease. Arch Dis Child 2005;90:891. https://doi.org/10.1136/adc.2004.071332
  9. Hsu YH, Wang YH, Hsu WY, Lee YP. Kawasaki disease characterized by erythema and induration at the Bacillus Calmette-Guerin and purified protein derivative inoculation sites. Pediatr Infect Dis J 1987;6:576-8. https://doi.org/10.1097/00006454-198706000-00020
  10. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998;133:254-8. https://doi.org/10.1016/S0022-3476(98)70229-X
  11. Olivieri L, Arling B, Friberg M, Sable C. Coronary artery Z score regression equations and calculators derived from a large heterogeneous population of children undergoing echocardiography. J Am Soc Echocardiogr 2009;22:159-64. https://doi.org/10.1016/j.echo.2008.11.003
  12. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo: Ministry of Health and Welfare; 1984.
  13. Yu JJ, Jang WS, Ko HK, et al. Perivascular brightness of coronary arteries in Kawasaki disease. J Pediatr 2011;159:454-7. https://doi.org/10.1016/j.jpeds.2011.02.029
  14. Sudo D, Monobe Y, Yashiro M, et al. Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 2012;171:651-6. https://doi.org/10.1007/s00431-011-1630-3
  15. Yun SH, Yang NR, Park SA. Associated symptoms of Kawasaki disease. Korean Circ J 2011;41:394-8. https://doi.org/10.4070/kcj.2011.41.7.394
  16. Barone SR, Pontrelli LR, Krilov LR. The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test. Arch Pediatr Adolesc Med 2000;154:453-6. https://doi.org/10.1001/archpedi.154.5.453
  17. Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics 2010;125:e234-41. https://doi.org/10.1542/peds.2009-0606
  18. Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J 2006;25:241-4. https://doi.org/10.1097/01.inf.0000202067.50975.90
  19. Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY. Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 2006;39:387-91.
  20. Burns JC, Wiggins JW Jr, Toews WH, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 1986;109:759-63. https://doi.org/10.1016/S0022-3476(86)80689-8
  21. Rowley AH, Gonzalez-Crussi F, Gidding SS, Duffy CE, Shulman ST. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 1987;110:409-13. https://doi.org/10.1016/S0022-3476(87)80503-6
  22. Takayama J, Yanase Y, Kawasaki T. A study on erythematous change at the site of the BCG inoculation. Acta Pediatr Jpn 1982;86:567-72.
  23. Yanagawa H, Nakamura Y, Kawasaki T, Shigematsu I. Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86. Lancet 1986;2:1138-9.
  24. Manlhiot C, Christie E, McCrindle BW, Rosenberg H, Chahal N, Yeung RS. Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr 2012;171:657-62. https://doi.org/10.1007/s00431-011-1631-2
  25. Perrin L, Letierce A, Guitton C, Tran TA, Lambert V, Kone-Paut I. Comparative study of complete versus incomplete Kawasaki disease in 59 pediatric patients. Joint Bone Spine 2009;76:481-5. https://doi.org/10.1016/j.jbspin.2008.11.015
  26. Uehara R, Igarashi H, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guerin inoculation site. Pediatr Infect Dis J 2010;29:430-3. https://doi.org/10.1097/INF.0b013e3181cacede

Cited by

  1. Clinical and Epidemiological Characteristics of Kawasaki Disease vol.7, pp.8, 2012, https://doi.org/10.5812/jjm.11014
  2. Erythema at BCG Inoculation Site in Kawasaki Disease Patients vol.26, pp.4, 2014, https://doi.org/10.5455/msm.2014.26.256-260
  3. Two infants with tuberculid associated with Kawasaki disease vol.12, pp.11, 2012, https://doi.org/10.1080/21645515.2016.1208329
  4. CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF KAWASAKI DISEASE WITH SPECIAL REFERENCE TO CARDIAC INVOLVEMENT vol.3, pp.1, 2012, https://doi.org/10.18410/jebmh/2016/1
  5. BCG and Kawasaki disease in Mexico and Japan vol.13, pp.5, 2012, https://doi.org/10.1080/21645515.2016.1267083
  6. Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea vol.15, pp.1, 2017, https://doi.org/10.1186/s12969-017-0192-y
  7. Clinical Significance of the Bacille Calmette-Guérin Site Reaction in Kawasaki Disease Patients Aged Less than 18 Months vol.25, pp.3, 2018, https://doi.org/10.14776/piv.2018.25.e11
  8. Adjunctive kampo therapy for incomplete Kawasaki disease mimic associated with reaction at the bacillus Calmette-Guérin inoculation site vol.6, pp.1, 2012, https://doi.org/10.1002/tkm2.1208
  9. Measles infection causing Bacillus Calmette-Guérin reactivation: a case report vol.19, pp.1, 2012, https://doi.org/10.1186/s12887-019-1635-z
  10. Kawasaki Disease in Infants in the First 3 Months of Age in a Mexican Population: A Cautionary Tale vol.8, pp.None, 2020, https://doi.org/10.3389/fped.2020.00397
  11. Bacille Calmette-Guérin inoculation site changes and cardiac complications in patients with Kawasaki disease vol.106, pp.7, 2012, https://doi.org/10.1136/archdischild-2020-319543